The seven BTS discharge dates were, for HYBE's live events division, a production calendar rather than a reunion timeline, because the Q4 2024 contingency agreements with AsiaWorld-Expo and K-Arena Incheon were signed before the last discharge certificate cleared, the company having spent three fiscal years running investor presentations around a single thesis: group returns, tour runs, streaming window reopens. BTS licensing, merchandise, and touring revenue underwrote roughly 40 percent of HYBE's peak operating income, and the fallow period (fiscal years 2024 and 2025) managed through WeVerse subscriptions and the multi-label push that produced &TEAM and ILLIT did not close that gap. Everything else was already signed.

The ticket queues in Causeway Bay last month were physical, people with fan club membership cards lining up for a pre-sale that was, ultimately, digital, which is what a five-year scarcity premium looks like when the supply has been structurally withheld and then released at stadium scale. HYBE's 2025 annual report to the Korea Exchange named full-scale group touring as the primary H2 2026 revenue driver, filing that with the exchange four months before the tour was publicly announced. AsiaWorld-Expo confirmed six consecutive HK dates in May 2026, the longest single-act residency at that venue since Eason Chan's 2019 run. HYBE built this in 2024.